SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 7, 2026

GLUE

Monte Rosa Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

The insider selling cluster is too small to be directionally meaningful. Traders should not read a bearish signal into these routine post-exercise sales. Monitor for any larger insider unloading or changes in executive ownership patterns, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
GLUE ▼ -50.42% at T+60d
NEUTRAL call -50.42% · α vs SPY -52.73% · entry $24.06 → $11.93
Entry = T+0 close
Jul 7, 2026
via day close
T+1d
+1.91%
call +1.91% · α +1.07%
$24.52
settled 4mo ago
T+5d
-2.49%
call -2.49% · α -3.36%
$23.46
settled 3mo ago
T+20d
-35.12%
call -35.12% · α -38.39%
$15.61
settled 3mo ago
T+60d
-50.42%
call -50.42% · α -52.73%
$11.93
settled 26d ago

Price Chart

Loading chart...

Executive Summary

Multiple insiders at Monte Rosa Therapeutics (GLUE) sold shares totaling ~$494K over a one-week window, but the aggregate value is only ~0.025% of the $2.0B market cap — a trivial amount. The sales are predominantly associated with option exercises and tax-withholding events, which are routine liquidity transactions. No material informational signal is conveyed.

Key Financial Metrics

Direction
selling
Total Value
$494.0K
Insiders
3

Key Facts

  • Three insiders sold shares: Director Anthony Manning ($231K), CSO Sharon Townson ($130K), CMO Filip Janku ($132K).
  • CSO Townson also exercised 12,000 options (non-cash) and sold a portion to cover taxes, a standard pattern.
  • Total open-market sales of ~$494K represent only 0.025% of GLUE's $2.0B market capitalization.
  • No CEO, CFO, or other top executives participated in the selling cluster.
  • The cluster is well below the 0.1% market-cap threshold that would warrant a material signal.

Financial Impact

Total insider selling of ~$494K, which is negligible relative to the company's enterprise value.

dilutioninsider ownership

Risk Factors

  • Insider selling could accelerate if stock price continues to rise, but current levels are not alarming.
  • No other recent filings (e.g., earnings, guidance, M&A) exist to contextualize the trades, so the signal is weak.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GLUE-1783456914924
19 reports for GLUE
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 4 best @ T+60▲ +18.17%Apr 20, 2026
Filters
Rows
Reports for GLUE — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
8-K
BULLISH ★ 7/10
$11.26awaiting T+60—$10.48 (−6.93%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 5/10
$11.26awaiting T+60—$10.48 (−6.93%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$15.71awaiting T+60—$10.48 (−33.29%)
Jul 17, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.48 $9.89▼ −57.88%▼ −62.72%$10.48 (−55.37%)
Jul 7, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.06 $11.93▼ −50.42%▼ −52.73%$10.48 (−56.44%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.48 (−56.71%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.48 (−56.71%)
Jun 29, 2026
17w ago
144
NEUTRAL ★ 2/10
$24.20 $11.89▼ −50.87%▼ −54.43%$10.48 (−56.69%)
Jun 25, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.29 $12.60▼ −43.47%▼ −49.56%$10.48 (−52.98%)
Jun 2, 2026
20w ago
Insider Cluster
NEUTRAL ★ 3/10
$17.59 $14.32▼ −18.59%▼ −21.09%$10.48 (−40.42%)
Showing 10 of 19

US Market Status

Market Closed — Opens Tue (15h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 7, 2026